US Pediatric Cardiology Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

The US pediatric cardiology market size is projected to reach US$ 3,599.40 million by 2031 from US$ 2,541.22 million in 2023. The market is expected to register a CAGR of 4.4% during 2023–2031. Integration of AI and machine learning with pediatric cardiology is likely to bring new trends in the market in the coming years.

US Pediatric Cardiology Market Analysis

Pediatric cardiology is a specialized branch of medicine that focuses on diagnosing, treating, and managing heart conditions in infants, children, and adolescents. This field addresses a range of congenital (present at birth) and acquired heart defects, including conditions such as ventricular septal defects, atrial septal defects, and more complex issues requiring surgical intervention. The US pediatric cardiology market growth is driven by surging incidences of congenital heart defects among Pediatrics and a growing shift toward minimally invasive procedures. Companies are taking numerous initiatives in the field of pediatric cardiology, which are expected to offer significant opportunities for the market growth during the forecast period.

US Pediatric Cardiology Market Overview

The US houses a few of the major market players, which are focused on research and development of innovative products specifically tailored to cater to the pediatric population. This has led to an increasing number of product launches. Additionally, supportive government policies and initiatives such as awareness campaigns and funding for the development of innovative and novel devices for the treatment of pediatric cardiology disorders are expected to support the US market growth in the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

US Pediatric Cardiology Market: Strategic Insights

US Pediatric Cardiology Market

• Market Size 2023
  US$ 2,541.22 Million
• Market Size 2031
  US$ 3,599.40 Million

Market Dynamics

GROWTH DRIVERS

• Surging incidences of congenital heart defects among pediatrics drives the dental burs market

FUTURE TRENDS

• Integration of AI and Machine Learning with Pediatric Cardiology likely to bring in new trends in the market in the upcoming years

OPPORTUNITIES

• Strategic Initiatives by Companies anticipated to create lucrative opportunities for the dental burs market growth

Regional Overview

• US

Market Segmentation

Product Type

• Transcatheter Heart Valves
• Occlusion Devices
• Atherectomy Devices
• Catheters
• Stents
• Introducer Sheaths

Surgical Procedures

• Interventional Procedures
• Heart Rhythm Management Procedures

End User

• Hospitals
• Specialty Clinics

Disease Indication

• Patient Foramen Ovale
• Congenital Heart Disease
• Acquired Heart Disease
• Arrhythmias
• Cardiomyopathies

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

US Pediatric Cardiology Market Drivers and Opportunities

Increasing Incidence of Congenital Heart Disease in Pediatrics

Chronic congenital heart disease (CCHD), tetralogy of fallot, ventricular septal defect, and atrial septal defect are a few congenital heart diseases (CHDs) that are present from birth. The rising prevalence of maternal health issues, such as diabetes and obesity, has been linked to an increased risk of CHD in newborns. According to the Children's Heart Foundation, CHD is the most common congenital disability in the US. As per the same source, approximately one of every 110 babies is born with a CHD, and each year, ~40,000 babies are born with CHD in the US. In 2023, approximately 20 of every 10,000 babies born in the US were suffering from CCHD, as per the American Academy of Pediatrics. According to the Centers for Disease Control and Prevention (CDC), about 1 in 2,077 babies, that is ~1,768 babies every year in the US, are born with tetralogy of fallot. Furthermore, 13 of every 10,000 babies, about 5,240 babies, in the US each year suffer from atrial septal defects at birth. In addition, about 42 of every 10,000 babies, or ~16,800 babies in the US, are born with ventricular septal defects each year. As survival rates for infants with CHD improve due to advancements in medical care, there is a growing population of children and adolescents requiring ongoing cardiology services. This shift has resulted in a heightened demand for specialized pediatric cardiac care, including diagnostic, surgical, and therapeutic interventions. Thus, the increasing incidence of various congenital heart diseases (CHDs) in the pediatric population fuels the growth of the US pediatric cardiology market.

Strategic Initiatives by Companies

Companies operating in the US pediatric cardiology market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them boost their sales, geographic reach, and capacities to cater to a wide customer base. A few strategic initiatives taken by key players operating in the US pediatric cardiology market are mentioned below:

• In August 2024, the Alliance for Pediatric Device Innovation (APDI) partnered with Additional Ventures to solicit proposals and offer grant funding for the development of pediatric devices specifically evaluated and labeled for children with heart conditions. Additional Ventures is a nonprofit foundation focused on accelerating research progress and improving clinical care for individuals born with single-ventricle heart defects. APDI and Additional Ventures are soliciting proposals for pediatric heart devices with a US$ 300,000 grant fund.
• In May 2024, Stanford Medicine researchers developed an implantable ventricular assist device that allows children suffering from heart failure to live relatively normal lives while they get a transplant. The pump, a new type of ventricular assist device, or VAD, is surgically attached to the heart to enhance its blood-pumping action in such children, which helps delay heart failure and provide time to locate a donor's heart.
• In January 2024, Occlutech received the United States Food and Drug Administration (FDA) for Occlutech Pistol Pusher and Occlutech ASD Occluder for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately commence commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc. The Occlutech ASD occluder is a nitinol, self-expanding, double-disc occlusion device that comprises two umbrella-shaped flexible discs with a waist in the middle connecting the two discs.

Therefore, strategic initiatives by various companies focusing on the development of pediatric cardiology devices are likely to offer growth opportunities to the US pediatric cardiology market in the coming years.

US Pediatric Cardiology Market Report Segmentation Analysis

Key segments that contributed to the derivation of the US pediatric cardiology market analysis are product type, surgical procedures, disease indication, and end user.

• In terms of product type, the US pediatric cardiology market is segmented into transcatheter heart valves, occlusion devices, atherectomy devices, catheters, stents, introducer sheaths, and others. The catheters segment held the largest share of the market in 2023.
• Based on surgical procedures, the market is categorized into interventional procedures, heart rhythm management procedures, and others. The interventional procedures dominated the market in 2023.
• Based on disease indication, the market is segmented into patent foramen ovale, congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. The acquired heart disease segment held the largest share of the market in 2023.
• By end users, the market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023.

US Pediatric Cardiology Market Share Analysis by Country

The US pediatric cardiology market is a dynamic and rapidly evolving sector, primarily driven by the increasing prevalence of congenital heart defects. According to the Children's Heart Foundation, CHD is the most common congenital disability in the US. As per the same source, approximately one of every 110 babies is born with a CHD, and each year, ~40,000 babies are born with CHD in the US. In 2023, approximately 20 of every 10,000 babies born in the US were suffering from CCHD, as per the American Academy of Pediatrics. This has increased the demand for specialized care and advancements in diagnostic tools, treatments, and technologies tailored specifically for pediatric patients. Key players in the market, such as Abbott Laboratories and Occlutech US LLC, are actively investing in research and development to innovate solutions that enhance patient outcomes, focusing on minimally invasive procedures that reduce recovery times and improve safety.

US Pediatric Cardiology Market Market Report Scope

US Pediatric Cardiology Market News and Recent Developments

The US pediatric cardiology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the US pediatric cardiology market are listed below:

• Renata Medical received the Food and Drug Administration approval for a new Minima stent device specifically tailored for neonates, infants, and young children, as well as designed to be re-expanded over their growth period. This approval marks a groundbreaking advancement in the care of young children facing congenital heart defects. (Source: Renata Medical, Company Website, August 2024)
• Occlutech received the United States Food and Drug Administration (FDA) for Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment of Atrial Septal Defects (ASD). With this approval, Occlutech will immediately begin commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc. (B. Braun Interventional Systems). (Source: Occlutech US LLC, Press Release, January 2024)

US Pediatric Cardiology Market Report Coverage and Deliverables

The "US Pediatric Cardiology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• US pediatric cardiology market size and forecast at country levels for all the key market segments covered under the scope
• US pediatric cardiology market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• US pediatric cardiology market analysis covering key market trends, country framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the US pediatric cardiology market
• Detailed company profiles